Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Charles Cliff Duncan
5 Nov 2026
Director
Buy
5,803
$3.80
$22.08K
Charles Cliff Duncan
4 Nov 2026
Director
Buy
3,447
$3.82
$13.17K
Charles Cliff Duncan
3 Nov 2026
Director
Buy
750
$3.80
$2.85K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 1,437,537
History held since 3 Nov 2006